Bronwyn has led Accord since 2000, introducing a strategic management focus that has delivered significant beneficial outcomes for the industry and seen Accord’s membership grow by more than 90 percent.
She has many years’ experience in pharmacy practice and has held senior positions as a regulatory and technical executive in the private sector, including Boehringer Ingleheim (UK and Australia) and the Australian Self Medication Industry (ASMI).
Independent of her Accord role, Bronwyn was the only industry representative appointed by the Minister to the National Drugs & Poison Scheduling Committee (NDPSC) from 1994 until it was disbanded in July 2010. She was then appointed as the industry expert on its replacement, the Advisory Committee on Chemicals Scheduling (ACCS) until end 2014. Bronwyn was an expert member of the Advisory Board to the Agricultural Pesticides and Veterinary Medicines Authority (APVMA)’s CEO appointed by the Minister until it was disbanded in November 2015. She was also the first regulatory affairs specialist appointed to the Australian Government’s Medicines Evaluation Committee (MEC).
Bronwyn was also appointed a member of the Chemicals & Plastics Leadership Group (CPLG) by Minister Macfarlane in 2002 and chaired the CPLG’s Regulatory Reform Working Group. She continues to be highly engaged in the significant reform agenda of the industry at a national and international level, being represented on senior stakeholder and consultation bodies of Australian regulatory agencies, and through participation in fora such the APEC Chemical Dialogue and the UN Strategic Approach to International Chemical Management (SAICM).